Natixis Advisors’s AngioDynamics ANGO Stock Holding History

Natixis Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50,274	Closed	-$926K	–	1118
2019 Q3	$926K	Sell	50,274 -14,087	-22%	-$275K	0.01%	948
2019 Q2	$1.27M	Buy	64,361 +29,061	+82%	+$592K	0.01%	875
2019 Q1	$807K	Sell	35,300 -126	-0.4%	-$2.73K	0.01%	948
2018 Q4	$713K	Sell	35,426 -1,386	-4%	-$28.7K	0.01%	977
2018 Q3	$799K	Buy	36,812 +1,020	+3%	+$22.7K	0.01%	989
2018 Q2	$796K	Buy	+35,792	New	+$732K	0.01%	971

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Natixis Advisors's ANGO Position: Q4 2019 in Review

Natixis Advisors sold out of AngioDynamics (ANGO) in Q4 2019, closing a stake of 50,274 shares — an estimated $926K sold.

Natixis Advisors first reported a position in ANGO in Q2 2018 and held it in 6 quarters. The position peaked at $1.27M in Q2 2019. 157 funds tracked by Wall St. Rank hold ANGO as of Q4 2019.

Natixis Advisors reported no remaining AngioDynamics position as of Q4 2019 after selling out during the quarter.
Natixis Advisors sold 50,274 AngioDynamics shares in Q4 2019, an estimated $926K.
Natixis Advisors first reported a position in AngioDynamics in Q2 2018 and held it in 6 quarters.
Natixis Advisors's AngioDynamics position peaked at $1.27M in Q2 2019.
157 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2019.

Based on Natixis Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.